Chronic Obstructive Pulmonary Disease and the Optimal Timing of Lung Transplantation

Overview

Journal Medicina (Kaunas)

Publisher MDPI

Specialty General Medicine

Date 2019 Sep 29

PMID 31561607

Authors

Rodrigo Vazquez Guillamet

Affiliations

Soon will be listed here.

Abstract

Chronic obstructive pulmonary disease (COPD) accounts for the largest proportion of respiratory deaths worldwide and was historically the leading indication for lung transplantation. The success of lung transplantation procedures is measured as survival benefit, calculated as survival with transplantation minus predicted survival without transplantation. In chronic obstructive pulmonary disease, it is difficult to show a clear and consistent survival benefit. Increasing knowledge of the risk factors, phenotypical heterogeneity, systemic manifestations, and their management helps improve our ability to select candidates and list those that will benefit the most from the procedure.

References

Pavord I, Wardlaw A . The A to E of airway disease. Clin Exp Allergy. 2010; 40(1):62-7. DOI: 10.1111/j.1365-2222.2009.03410.x. View

Liu V, Zamora M, Dhillon G, Weill D . Increasing lung allocation scores predict worsened survival among lung transplant recipients. Am J Transplant. 2010; 10(4):915-920. PMC: 2860663. DOI: 10.1111/j.1600-6143.2009.03003.x. View

Wagner D, Amrein K, Dimai H, Kniepeiss D, Tscheliessnigg K, Kornprat P . Ibandronate and calcitriol reduces fracture risk, reverses bone loss, and normalizes bone turnover after LTX. Transplantation. 2012; 93(3):331-6. DOI: 10.1097/TP.0b013e31823f7f68. View

Hartl S, Lopez-Campos J, Pozo-Rodriguez F, Castro-Acosta A, Studnicka M, Kaiser B . Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD Audit. Eur Respir J. 2015; 47(1):113-21. DOI: 10.1183/13993003.01391-2014. View

Cote C, Pinto-Plata V, Marin J, Nekach H, Dordelly L, Celli B . The modified BODE index: validation with mortality in COPD. Eur Respir J. 2008; 32(5):1269-74. DOI: 10.1183/09031936.00138507. View

Boutou A, Shrikrishna D, Tanner R, Smith C, Kelly J, Ward S . Lung function indices for predicting mortality in COPD. Eur Respir J. 2013; 42(3):616-25. PMC: 3759303. DOI: 10.1183/09031936.00146012. View

Puhan M, Hansel N, Sobradillo P, Enright P, Lange P, Hickson D . Large-scale international validation of the ADO index in subjects with COPD: an individual subject data analysis of 10 cohorts. BMJ Open. 2012; 2(6). PMC: 3533065. DOI: 10.1136/bmjopen-2012-002152. View

Yi S, Burroughs S, Loebe M, Scheinin S, Seethamraju H, Jyothula S . Combined lung and liver transplantation: analysis of a single-center experience. Liver Transpl. 2013; 20(1):46-53. DOI: 10.1002/lt.23770. View

Vock D, Durheim M, Tsuang W, Finlen Copeland C, Tsiatis A, Davidian M . Survival Benefit of Lung Transplantation in the Modern Era of Lung Allocation. Ann Am Thorac Soc. 2016; 14(2):172-181. PMC: 5427730. DOI: 10.1513/AnnalsATS.201606-507OC. View

10.

Han M, Kim M, Mardon R, Renner P, Sullivan S, Diette G . Spirometry utilization for COPD: how do we measure up?. Chest. 2007; 132(2):403-9. DOI: 10.1378/chest.06-2846. View

11.

Espantoso-Romero M, Roman Rodriguez M, Duarte-Perez A, Gonzalvez-Rey J, Callejas-Cabanillas P, Lazic D . External validation of multidimensional prognostic indices (ADO, BODEx and DOSE) in a primary care international cohort (PROEPOC/COPD cohort). BMC Pulm Med. 2016; 16(1):143. PMC: 5106777. DOI: 10.1186/s12890-016-0305-2. View

12.

Johnson E, Leverson G, Pirsch J, Heise C . A 30-year analysis of colorectal adenocarcinoma in transplant recipients and proposal for altered screening. J Gastrointest Surg. 2007; 11(3):272-9. DOI: 10.1007/s11605-007-0084-4. View

13.

Reed R, Cabral H, Dransfield M, Eberlein M, Merlo C, Mulligan M . Survival of Lung Transplant Candidates With COPD: BODE Score Reconsidered. Chest. 2017; 153(3):697-701. PMC: 5989634. DOI: 10.1016/j.chest.2017.10.008. View

14.

Baty F, Putora P, Isenring B, Blum T, Brutsche M . Comorbidities and burden of COPD: a population based case-control study. PLoS One. 2013; 8(5):e63285. PMC: 3656944. DOI: 10.1371/journal.pone.0063285. View

15.

Wilson M, Vakil A, Kandel P, Undavalli C, Dunlay S, Kennedy C . Pretransplant frailty is associated with decreased survival after lung transplantation. J Heart Lung Transplant. 2015; 35(2):173-8. DOI: 10.1016/j.healun.2015.10.014. View

16.

Shane E, Papadopoulos A, Staron R, Addesso V, Donovan D, McGregor C . Bone loss and fracture after lung transplantation. Transplantation. 1999; 68(2):220-7. DOI: 10.1097/00007890-199907270-00010. View

17.

Lahzami S, Bridevaux P, Soccal P, Wellinger J, Robert J, Ris H . Survival impact of lung transplantation for COPD. Eur Respir J. 2009; 36(1):74-80. DOI: 10.1183/09031936.00087809. View

18.

Petersen H, Vazquez Guillamet R, Meek P, Sood A, Tesfaigzi Y . Early Endotyping: A Chance for Intervention in Chronic Obstructive Pulmonary Disease. Am J Respir Cell Mol Biol. 2018; 59(1):13-17. PMC: 6039877. DOI: 10.1165/rcmb.2018-0002PS. View

19.

Beyer D, Mitfessel H, Gillissen A . Maternal smoking promotes chronic obstructive lung disease in the offspring as adults. Eur J Med Res. 2010; 14 Suppl 4:27-31. PMC: 3521336. DOI: 10.1186/2047-783x-14-s4-27. View

20.

Divo M, Cote C, de Torres J, Casanova C, Marin J, Pinto-Plata V . Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012; 186(2):155-61. DOI: 10.1164/rccm.201201-0034OC. View